183 related articles for article (PubMed ID: 15560319)
1. Mirtazapine for treatment of nausea induced by selective serotonin reuptake inhibitors.
Caldis EV; Gair RD
Can J Psychiatry; 2004 Oct; 49(10):707. PubMed ID: 15560319
[No Abstract] [Full Text] [Related]
2. Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function.
Ravindran LN; Eisfeld BS; Kennedy SH
J Clin Psychopharmacol; 2008 Feb; 28(1):107-8. PubMed ID: 18204355
[No Abstract] [Full Text] [Related]
3. Antagonism of selective serotonin reuptake inhibitor-induced nausea by mirtazapine.
Pedersen L; Klysner R
Int Clin Psychopharmacol; 1997 Jan; 12(1):59-60. PubMed ID: 9179636
[No Abstract] [Full Text] [Related]
4. Dual action antidepressants and some important considerations.
Gupta RK; Tiller JW; Burrows GD
Aust N Z J Psychiatry; 2003 Apr; 37(2):190-5. PubMed ID: 12656958
[TBL] [Abstract][Full Text] [Related]
5. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Al-Adwani A
Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
[No Abstract] [Full Text] [Related]
6. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Benazzi F
Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
[No Abstract] [Full Text] [Related]
7. Olanzapine and mirtazapine for multiple palliation.
J Support Oncol; 2003; 1(1):64. PubMed ID: 15352645
[No Abstract] [Full Text] [Related]
8. Sertraline- and mirtazapine-induced severe neutropenia.
Ozcanli T; Unsalver B; Ozdemir S; Ozmen M
Am J Psychiatry; 2005 Jul; 162(7):1386. PubMed ID: 15994730
[No Abstract] [Full Text] [Related]
9. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
[TBL] [Abstract][Full Text] [Related]
10. Mirtazapine for new daily persistent headache-associated chronic nausea.
Smith JH
Headache; 2015 Jan; 55(1):176-7. PubMed ID: 25262618
[No Abstract] [Full Text] [Related]
11. Comment: serotonin syndrome induced by fluvoxamine and mirtazapine.
Isbister GK; Dawson AH; Whyte IM
Ann Pharmacother; 2001 Dec; 35(12):1674-5. PubMed ID: 11793645
[No Abstract] [Full Text] [Related]
12. Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors.
Ozmenler NK; Karlidere T; Bozkurt A; Yetkin S; Doruk A; Sutcigil L; Cansever A; Uzun O; Ozgen F; Ozsahin A
Hum Psychopharmacol; 2008 Jun; 23(4):321-6. PubMed ID: 18278806
[TBL] [Abstract][Full Text] [Related]
13. Sertraline-induced serotonin syndrome followed by mirtazapine reaction.
Butler MC; Di Battista M; Warden M
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1128-9. PubMed ID: 20430060
[No Abstract] [Full Text] [Related]
14. A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
Papakostas GI; Homberger CH; Fava M
J Psychopharmacol; 2008 Nov; 22(8):843-8. PubMed ID: 18308801
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of the new antidepressants.
Nelson JC
J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
[TBL] [Abstract][Full Text] [Related]
16. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitor and akathisia.
Poyurovsky M; Weizman A
J Clin Psychopharmacol; 1997 Dec; 17(6):489. PubMed ID: 9408813
[No Abstract] [Full Text] [Related]
18. Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.
Farah A
J Clin Psychiatry; 1999 Apr; 60(4):260-1. PubMed ID: 10221289
[No Abstract] [Full Text] [Related]
19. Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
Egami M; Imamura Y; Nabeta H; Mizoguchi Y; Yamada S
Hum Psychopharmacol; 2013 Jan; 28(1):7-14. PubMed ID: 23124792
[TBL] [Abstract][Full Text] [Related]
20. Mirtazapine withdrawal symptoms.
Benazzi F
Can J Psychiatry; 1998 Jun; 43(5):525. PubMed ID: 9653542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
